Laser ablation of embryonic veins in children

Mark Bittles, Diana S. Jodeh, Jennifer L.R. Mayer, Michael Gallant, Stephen Rottgers

Research output: Contribution to journalArticle

Abstract

Background: Klippel–Trenaunay syndrome (KTS) and related overgrowth syndromes are rare conditions that often present to academic pediatric units and multidisciplinary vascular anomaly clinics. These conditions are commonly associated with abnormalities of the superficial and deep venous structures and carry an increased risk of venous thromboembolism. Methods: A retrospective chart review was completed of all patients treated at Johns Hopkins All Children's Hospital with endovenous laser ablation therapy (EVLT) for management of dilated embryonic veins in the setting of limb overgrowth. Results: Three patients with limb overgrowth underwent EVLT between 2015 and 2017. All patients had successful occlusion of the targeted veins on post-procedure imaging. One patient developed a cellulitis successfully treated with oral antibiotics. Conclusions: Endovenous laser ablation therapy is a well-tolerated and safe procedure for prophylactic closure of abnormal superficial embryonic veins. This study supports the use of this technique in managing increased thromboembolic risk in this unique patient population and recognizes the need for a long-term study to determine its efficacy.

Original languageEnglish (US)
Pages (from-to)358-363
Number of pages6
JournalPediatrics International
Volume61
Issue number4
DOIs
StatePublished - Apr 1 2019
Externally publishedYes

Fingerprint

Laser Therapy
Veins
Extremities
Cellulitis
Venous Thromboembolism
Blood Vessels
Pediatrics
Anti-Bacterial Agents
Population

Keywords

  • endovenous laser ablation
  • Klippel–Trenaunay syndrome
  • overgrowth syndromes
  • varicose veins
  • venous malformation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Bittles, M., Jodeh, D. S., Mayer, J. L. R., Gallant, M., & Rottgers, S. (2019). Laser ablation of embryonic veins in children. Pediatrics International, 61(4), 358-363. https://doi.org/10.1111/ped.13804

Laser ablation of embryonic veins in children. / Bittles, Mark; Jodeh, Diana S.; Mayer, Jennifer L.R.; Gallant, Michael; Rottgers, Stephen.

In: Pediatrics International, Vol. 61, No. 4, 01.04.2019, p. 358-363.

Research output: Contribution to journalArticle

Bittles, M, Jodeh, DS, Mayer, JLR, Gallant, M & Rottgers, S 2019, 'Laser ablation of embryonic veins in children', Pediatrics International, vol. 61, no. 4, pp. 358-363. https://doi.org/10.1111/ped.13804
Bittles, Mark ; Jodeh, Diana S. ; Mayer, Jennifer L.R. ; Gallant, Michael ; Rottgers, Stephen. / Laser ablation of embryonic veins in children. In: Pediatrics International. 2019 ; Vol. 61, No. 4. pp. 358-363.
@article{32ddf4dd14e54553a840209c3e2439f7,
title = "Laser ablation of embryonic veins in children",
abstract = "Background: Klippel–Trenaunay syndrome (KTS) and related overgrowth syndromes are rare conditions that often present to academic pediatric units and multidisciplinary vascular anomaly clinics. These conditions are commonly associated with abnormalities of the superficial and deep venous structures and carry an increased risk of venous thromboembolism. Methods: A retrospective chart review was completed of all patients treated at Johns Hopkins All Children's Hospital with endovenous laser ablation therapy (EVLT) for management of dilated embryonic veins in the setting of limb overgrowth. Results: Three patients with limb overgrowth underwent EVLT between 2015 and 2017. All patients had successful occlusion of the targeted veins on post-procedure imaging. One patient developed a cellulitis successfully treated with oral antibiotics. Conclusions: Endovenous laser ablation therapy is a well-tolerated and safe procedure for prophylactic closure of abnormal superficial embryonic veins. This study supports the use of this technique in managing increased thromboembolic risk in this unique patient population and recognizes the need for a long-term study to determine its efficacy.",
keywords = "endovenous laser ablation, Klippel–Trenaunay syndrome, overgrowth syndromes, varicose veins, venous malformation",
author = "Mark Bittles and Jodeh, {Diana S.} and Mayer, {Jennifer L.R.} and Michael Gallant and Stephen Rottgers",
year = "2019",
month = "4",
day = "1",
doi = "10.1111/ped.13804",
language = "English (US)",
volume = "61",
pages = "358--363",
journal = "Pediatrics International",
issn = "1328-8067",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Laser ablation of embryonic veins in children

AU - Bittles, Mark

AU - Jodeh, Diana S.

AU - Mayer, Jennifer L.R.

AU - Gallant, Michael

AU - Rottgers, Stephen

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Background: Klippel–Trenaunay syndrome (KTS) and related overgrowth syndromes are rare conditions that often present to academic pediatric units and multidisciplinary vascular anomaly clinics. These conditions are commonly associated with abnormalities of the superficial and deep venous structures and carry an increased risk of venous thromboembolism. Methods: A retrospective chart review was completed of all patients treated at Johns Hopkins All Children's Hospital with endovenous laser ablation therapy (EVLT) for management of dilated embryonic veins in the setting of limb overgrowth. Results: Three patients with limb overgrowth underwent EVLT between 2015 and 2017. All patients had successful occlusion of the targeted veins on post-procedure imaging. One patient developed a cellulitis successfully treated with oral antibiotics. Conclusions: Endovenous laser ablation therapy is a well-tolerated and safe procedure for prophylactic closure of abnormal superficial embryonic veins. This study supports the use of this technique in managing increased thromboembolic risk in this unique patient population and recognizes the need for a long-term study to determine its efficacy.

AB - Background: Klippel–Trenaunay syndrome (KTS) and related overgrowth syndromes are rare conditions that often present to academic pediatric units and multidisciplinary vascular anomaly clinics. These conditions are commonly associated with abnormalities of the superficial and deep venous structures and carry an increased risk of venous thromboembolism. Methods: A retrospective chart review was completed of all patients treated at Johns Hopkins All Children's Hospital with endovenous laser ablation therapy (EVLT) for management of dilated embryonic veins in the setting of limb overgrowth. Results: Three patients with limb overgrowth underwent EVLT between 2015 and 2017. All patients had successful occlusion of the targeted veins on post-procedure imaging. One patient developed a cellulitis successfully treated with oral antibiotics. Conclusions: Endovenous laser ablation therapy is a well-tolerated and safe procedure for prophylactic closure of abnormal superficial embryonic veins. This study supports the use of this technique in managing increased thromboembolic risk in this unique patient population and recognizes the need for a long-term study to determine its efficacy.

KW - endovenous laser ablation

KW - Klippel–Trenaunay syndrome

KW - overgrowth syndromes

KW - varicose veins

KW - venous malformation

UR - http://www.scopus.com/inward/record.url?scp=85064500458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064500458&partnerID=8YFLogxK

U2 - 10.1111/ped.13804

DO - 10.1111/ped.13804

M3 - Article

C2 - 30742735

AN - SCOPUS:85064500458

VL - 61

SP - 358

EP - 363

JO - Pediatrics International

JF - Pediatrics International

SN - 1328-8067

IS - 4

ER -